Marine Sulfated Polysaccharide PMGS Synergizes with Paclitaxel in Inhibiting Cervical Cancer In Vitro

Area of Science:

• Oncology
• Marine Biotechnology
• Pharmacology

Background:

• Cervical cancer is a leading cause of cancer mortality in women globally.
• Paclitaxel (PTX) is a standard chemotherapy, but faces challenges like side effects and resistance.
• Marine sulfated polysaccharides (PMGS) have demonstrated anti-human papillomavirus (anti-HPV) properties.

Purpose of the Study:

• To investigate the potential synergistic anti-tumor effects of PMGS combined with PTX in HPV-associated cervical cancer.
• To explore the underlying mechanisms of this combination therapy in vitro.

Main Methods:

• In vitro study using Hela cervical cancer cells.
• Evaluation of cell proliferation, cytotoxicity, apoptosis, and migration.
• Combination treatment with PMGS and PTX.

Main Results:

• PMGS and PTX individually inhibited cervical cancer cell proliferation.
• The combination of PMGS and PTX exhibited significant synergistic anti-tumor effects on Hela cells.
• PMGS enhanced PTX's efficacy by increasing cytotoxicity, inducing apoptosis, and inhibiting cell migration.

Conclusions:

• PMGS acts as a sensitizer, enhancing the anti-cancer activity of PTX against HPV-associated cervical cancer.
• The combination of PTX and PMGS presents a promising novel therapeutic strategy for cervical cancer treatment.
• Further research is warranted to explore this combination in clinical settings.